Table 1. Demographic and clinical characteristics of the first 50 patients whose sera were evaluated.
| TB | No TB | |||
|---|---|---|---|---|
| Culture positive | Culture negative | Total | p value | |
| N. 10 | N. 40 | N. 50 | ||
| Age median (IQR) | 28.5 (23–40) | 40 (25–54) | 38.0 (24–50.5) | .0183 |
| Sex, MALE N (%) | 7 (70%) | 22 (55) | 29 (58) | 0.389 |
| AFB smear score/total (%) | Score 0: 0 | Score 0: 38 (95) | Score 0/ 38 (76) | <0.001 |
| Score 1: 4(40) | Score 1: 2 (5) | Score 1/ 6 (12) | ||
| Score 2: 3(30) | Score 2/ 3 (6) | |||
| Score 3: 3(30) | Score 3/ 3(6) | |||
| Solid and/or liquid culture positive | 10 (100) | 0 | 10 (20) | NA |
| BCG vaccination recorded N (%) | 7 (70) | 22 (55) | 29 (58) | 0.380 |
| Previous TB reported N (%) | 1 (10) | 6 (15) | 7 (14) | 0.504 |
| Other diseases N (%) | 2 (20) | 7 (17.5) | 9 (18) | |
| Site: Pulmonary | 8 (80) | 40 (100) | 48 (96) | 0.178 |
| Extra-pulmonary/pulmonary | 1 (10) | 0 | 1 (2) | |
| Unknown | 1 (10) | 0 | 1 (2) | |
| Region of Origin N (%) | Asia 5 (50) | Asia 13 (32.5) | Asia 18 (36) | <0.001 |
| Africa 5 (50) | Africa 7 (17.5) | Africa 12 (24) | ||
| S. America 20 (50) | S. America 20 (40) |